Ningxia Zhongke Biotechnology Co., Ltd.SSE: 600165

Announcement on New and Accumulative Litigation

Mar 18, 2026 · Issued by Ningxia Zhongke Biotechnology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Mar 18, 2026

On 6ix: 6ix.com/news/announcement-on-new-and-accumulative-litigation-1

Announcement on New and Accumulative Litigation

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Ningxia Zhongke Biotechnology Co., Ltd. on 6ix

Earlier from Ningxia Zhongke Biotechnology

Announcement on Completion of Industrial and Commercial Change Registration for Registered Capital and Renewal of Business LicenseMar 10
Announcement on Litigation Involved by the Company and Its SubsidiaryMar 7
Announcement on Results of the Judicial Auction of Shares of the Company Held by Shanghai Zhongneng Enterprise Development (Group) Co., Ltd.Feb 5
Announcement on Outward Investment in Establishing SubsidiariesJan 31
Announcement on Expected Loss in Performance for 2025Jan 20

Later from Ningxia Zhongke Biotechnology

Announcement on Resolutions of the 3rd Meeting of the 10th Board of DirectorsMar 28
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Apr 14
Announcement on Providing Guarantee for Holding SubsidiaryApr 24
Announcement on the Filing of Infringement Lawsuits by the Company and Its SubsidiariesApr 28
Report for Q1 2026Apr 30

All Ningxia Zhongke Biotechnology news releases

Follow Ningxia Zhongke Biotechnology into a list and get an email when it puts out news.

Follow Ningxia Zhongke Biotechnology